Tratamiento del dolor neuropático con lacosamida

García-Escrivá, Alexandre; López-Hernández, Nicolás; Gil-Cortés, Cristina.
Rev. neurol. (Ed. impr.) ; 54(3): 167-172, 1 feb., 2012. ilus
Artículo en Español | IBECS (España) | ID: ibc-99968

Documentos relacionados

  1. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series.
  2. Seizures in trisomy 18: Prevalence, description, and treatment.
  3. Status Epilepticus: An Update on Pharmacological Management.
  4. Dorsal root ganglion stimulator-A targeted therapy for post-herpetic neuralgia: The Middle East Experience.
  5. Preventing Teratogenicity in Women with Epilepsy.
  6. Antiepileptic drug withdrawal in juvenile myoclonic epilepsy.
  7. Population pharmacokinetics and dosing optimization of perampanel in children with epilepsy: A real-world study.
  8. Therapeutic drug monitoring in pregnancy: Levetiracetam.
  9. Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy.
  10. Tricyclic antidepressants and selective serotonin reuptake inhibitors but not anticonvulsants ameliorate pain, anxiety, and depression symptoms in an animal model of central post-stroke pain.